Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma

被引：1
|
作者：
Gambichler, T. [1 ]
Scholl, L. [1 ]
机构：
[1] Ruhr Univ Bochum, Dept Dermatol Venereol & Allergol, Skin Canc Ctr, Bochum, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2013年 / 27卷 / 11期
关键词：
BIOPSY; LYMPHADENECTOMY; BENEFIT;
D O I：
10.1111/jdv.12087
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1454 / 1456
页数：3
相关论文
共 50 条
  • [21] Prognostic Significance of Sentinel Node Status in Patients with Thick Melanoma
    Bello, D.
    Han, G.
    Jackson, L.
    Bulloch, K.
    Ariyan, S.
    Narayan, D.
    Gould Rothberg, B.
    Han, D.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S120 - S120
  • [22] Histological regression in melanoma: impact on sentinel lymph node status and survival
    Aivazian, Karina
    Ahmed, Tasnia
    El Sharouni, Mary-Ann
    Stretch, Jonathan R.
    Saw, Robyn P. M.
    Spillane, Andrew J.
    Shannon, Kerwin F.
    Ch'ng, Sydney
    Nieweg, Omgo E.
    Thompson, John F.
    Lo, Serigne N.
    Scolyer, Richard A.
    MODERN PATHOLOGY, 2021, 34 (11) : 1999 - 2008
  • [23] Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma
    Rodriguez Otero, Juan Carlos
    Dagatti, Maria Susana
    Bussy, Ramon Fernandez
    Bergero, Adriana
    Gorosito, Mario
    Staffieri, Roberto
    Villavicencio, Roberto
    Batalles, Stella Maris
    Pezzotto, Stella Maris
    WORLD JOURNAL OF ONCOLOGY, 2019, 10 (02) : 112 - 117
  • [24] LYMPH NODE METASTASIS IS THE MOST IMPORTANT PREDICTOR ON DISEASE-FREE AND OVERALL SURVIVAL IN PATIENTS WITH UTERINE CARCINOSARCOMA
    Taskin, S.
    Sukur, Y. E.
    Seval, M. M.
    Varli, B.
    Koyuncu, K.
    Gungor, M.
    Ortac, F.
    Ates, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1081 - 1082
  • [25] Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma
    Boada, Aram
    Tejera-Vaquerizo, Antonio
    Ribero, Simone
    Puig, Susana
    Moreno-Ramirez, David
    Quaglino, Pietro
    Osella-Abate, Simona
    Cassoni, Paola
    Malvehy, Josep
    Carrera, Cristina
    Pigem, Ramon
    Barreiro-Capurro, Alicia
    Requena, Celia
    Traves, Victor
    Manrique-Silva, Esperanza
    Fernandez-Orland, Almudena
    Ferrandiz, Lara
    Garcia-Senosiain, Oihane
    Fernandez-Figueras, Maria T.
    Ferrandiz, Carlos
    Nagore, Edurado
    EJSO, 2020, 46 (02): : 263 - 271
  • [26] Ethnicity is the Strongest Predictor of Lymph Node Status in Patients with Early Gastric Cancer
    Fukuhara, S.
    Montgomery, M. M.
    Yabe, M.
    Itagaki, S.
    Brower, S. T.
    Karpeh, M. S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S159 - S159
  • [27] Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
    Roach, Brent A.
    Burton, Alison L.
    Mays, Michael P.
    Ginter, Brooke A.
    Martin, Robert C. G.
    Stromberg, Arnold J.
    Hagendoorn, Lee
    McMasters, Kelly M.
    Scoggins, Charles R.
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (06): : 759 - 763
  • [28] Sentinel lymph node status as a prognostic indicator in patients with thick (T4) primary melanoma
    Council, M.
    Bowers, R. C.
    Lowe, J. B.
    Hussussian, C. J.
    Cornelius, L. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 144 - 144
  • [29] Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact
    Rutkowski, P
    Nowecki, ZI
    Nasierowska-Guttmejer, A
    Ruka, W
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (07): : 611 - 618
  • [30] Sentinel Lymph Node Biopsy Is Indicated for Patients With Thick Clinically Lymph Node-Negative Melanoma
    Yamamoto, Maki
    Fisher, Kate J.
    Wong, Joyce Y.
    Koscso, Jonathan M.
    Konstantinovic, Monique A.
    Govsyeyev, Nicholas
    Messina, Jane L.
    Sarnaik, Amod A.
    Cruse, C. Wayne
    Gonzalez, Ricardo J.
    Sondak, Vernon K.
    Zager, Jonathan S.
    CANCER, 2015, 121 (10) : 1628 - 1636
12345